JPRN-UMIN000044317招募中未知
Efficacy and Safety of SGLT2 inhibitors in patients with type 1 diabete. - SGLT2i in T1DM,Sapporo
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who were thought to be inappropriate to enter this study for some reasons by physician's judgments
研究者
相似试验
招募中
不适用
Efficacy and safety of SGLT2 inhibitor in patients with diabetic kidneyDiabetic nephropathyJPRN-UMIN000031454ihon University40
已完成
不适用
The efficacy and safety of SGLT2 inhibitor for non alcholic fatty liver disease in Japanese patients with type 2 diabetesJPRN-UMIN000016306Tokyo Medical and Dental University50
招募中
4 期
Efficacy of SGLT2 inhibitor for Non-Alcoholic Fatty Liver Diseaseon Alcoholic Fatty Liver DiseaseC06.552.241.519C18.452.394.750.149ObesityType 2 Diabetes MellitusRBR-48rxwbCentro Educacional Hyarte
招募中
4 期
Effects of SGLT-2 inhibitors for the patients with non-alcoholic fatty liver disease (NAFLD) complicated with type 2 diabetes mellitus.on-alcoholic fatty liver disease (NAFLD) complicated with type 2 diabetes mellitus.JPRN-UMIN000018913Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine50
已完成
不适用
ong-term efficacy and safety of the SGLT2 inhibitors in Japanese patients with type 2 diabetes mellitus.JPRN-UMIN000037872akakinen Clinic630